Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Julphar
Johnson and Johnson
Accenture
McKesson
UBS
Healthtrust
Federal Trade Commission
Colorcon

Generated: February 18, 2019

DrugPatentWatch Database Preview

Taro Pharm Inds Company Profile

« Back to Dashboard

What is the competitive landscape for TARO PHARM INDS, and when can generic versions of TARO PHARM INDS drugs launch?

TARO PHARM INDS has thirty-one approved drugs.

There are two US patents protecting TARO PHARM INDS drugs. There is one tentative approval on TARO PHARM INDS drugs.

There are ten patent family members on TARO PHARM INDS drugs in seven countries and nineteen supplementary protection certificates in nine countries.

Summary for Taro Pharm Inds
International Patents:10
US Patents:2
Tradenames:21
Ingredients:19
NDAs:31

Drugs and US Patents for Taro Pharm Inds

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro Pharm Inds Ltd TOPICORT desoximetasone GEL;TOPICAL 074904-001 Jul 14, 1998 AB RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial
Taro Pharm Inds LAMOTRIGINE lamotrigine TABLET;ORAL 078525-002 Jan 27, 2009 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Taro Pharm Inds Ltd TOPICORT desoximetasone CREAM;TOPICAL 073210-001 Nov 30, 1990 AB RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for TARO PHARM INDS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Topical Spray 0.25% ➤ Subscribe 2013-12-18
➤ Subscribe Topical Lotion 0.5% ➤ Subscribe 2011-03-16

Supplementary Protection Certificates for Taro Pharm Inds Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
00085 Netherlands ➤ Try a Free Trial PRODUCT NAME: LEVOCETIRIZINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER LEVOCETIRINE DIHYDROCHLORIDE; NAT. REGISTRATION NO/DATE: RVG 26770 20011009; FIRST REGISTRATION: DE 49903.00.00 AND 49904.00.00 20010103
C0004 France ➤ Try a Free Trial PRODUCT NAME: DESLORATADINE; PSEUDOEPHEDRINE SULFATE; REGISTRATION NO/DATE: EU/1/07/399/001 20070730
C0038 France ➤ Try a Free Trial PRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Baxter
Farmers Insurance
Accenture
Queensland Health
Federal Trade Commission
Teva
Dow
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.